FDA Approves Lilly's Orforglipron; Trump Pharma Tariffs Loom
FDA approves Eli Lilly's oral obesity pill orforglipron (Foundayo) while Trump eyes 100% tariffs on imported pharmaceuticals and drug ingredients.
Eli Lilly
3 articles tagged "Eli Lilly"
Novo Nordisk Faces Investor Pressure at 2026 Annual Meeting
Novo Nordisk faces shareholder scrutiny as its stock drops 45% since CEO ouster, while rival Eli Lilly surges to a $1 trillion market cap.
Eli Lilly's Retatrutide Cuts Blood Sugar & Weight in Trial
Eli Lilly's triple-G drug retatrutide showed significant HbA1C and weight reductions in type 2 diabetes patients at 40 weeks in a 2026 late-stage trial.